Zolmitriptan
CAS 139264-17-8
Visão geral
Zolmitriptan, sold under the brand name Zomig among others, is a triptan used in the acute treatment of migraine attacks with or without aura and cluster headaches. It is a selective serotonin receptor agonist of the 1B and 1D subtypes. It was patented in 1990 and approved for medical use in 1997
A Anant Labs fabrica e fornece impurezas de Zolmitriptan de alta qualidade para o mercado global. Nossas impurezas EP de Zolmitriptan são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.










